相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Short-term real-world outcomes following intravitreal brolucizumab for neovascular AMD: SHIFT study
Louisa Maria Bulirsch et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2022)
Brolucizumab-early real-world experience: BREW study
Ashish Sharma et al.
EYE (2021)
Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) - a meta-analysis
Justus G. Garweg et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
Ana Bety Enriquez et al.
JAMA OPHTHALMOLOGY (2021)
Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study
Alper Bilgic et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
Debdulal Chakraborty et al.
OPHTHALMOLOGY AND THERAPY (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Caroline R. Baumal et al.
OPHTHALMOLOGY (2020)
The Evolving Treatment of Diabetic Retinopathy
Sam E. Mansour et al.
CLINICAL OPHTHALMOLOGY (2020)
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry
Prethy Rao et al.
OPHTHALMOLOGY (2018)
Incidence and Outcomes of Infectious and Noninfectious Endophthalmitis after Intravitreal Injections for Age-Related Macular Degeneration
Vincent Daien et al.
OPHTHALMOLOGY (2018)
Epigenetics, microbiota, and intraocular inflammation: New paradigms of immune regulation in the eye
Xiaofeng Wen et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2018)
Genetic ancestry and population differences in levels of inflammatory cytokines in women: Role for evolutionary selection and environmental factors
Song Yao et al.
PLOS GENETICS (2018)
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial
Pravin U. Dugel et al.
OPHTHALMOLOGY (2017)
Safety Assessment and Power Analyses in Published Anti-Vascular Endothelial Growth Factor Randomized Controlled Trials
Fehim Esen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Anti-VEGF Therapy for Retinal Vein Occlusions
Claudio Campa et al.
CURRENT DRUG TARGETS (2016)
The Association of Race With Childhood Uveitis
Sheila T. Angeles-Han et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
Adnan Tufail et al.
OPHTHALMOLOGY (2014)
The Impact of Anti-Vascular Endothelial Growth Factor Treatment on Quality of Life in Neovascular Age-Related Macular Degeneration
Robert P. Finger et al.
OPHTHALMOLOGY (2014)
Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
Davin Johnson et al.
CURRENT OPINION IN OPHTHALMOLOGY (2013)
Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy
Shivi Agrawal et al.
MEDIATORS OF INFLAMMATION (2013)
Incidence and Prevalence of Uveitis Results From the Pacific Ocular Inflammation Study
Nisha R. Acharya et al.
JAMA OPHTHALMOLOGY (2013)
Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
Michael W. Stewart
CLINICAL OPHTHALMOLOGY (2012)
分享论文
